Glufosfamide: Phase II data

In an open-label Phase II trial in 22 patients, 1-hour infusions of 5,000 µg/m² of glufosfamide every 3 weeks gave 3 partial responses and 8 cases of stable disease. In the 20-month trial, 2 patients ...